GlassScriptPhysician profile
Brenda Goodwin
NPI 1033183462
$2,684.65
in general payments reported to CMS, 2019-2025
31 companies · $458 in 2025
The $458 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $639 · 2023: $708 · 2024: $880 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $395.44 | 2022-2024 | Mounjaro, Jardiance, Baqsimi |
| Beta Bionics, INC. | $244.89 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Bayer Healthcare Pharmaceuticals INC. | $221.63 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $201.27 | 2022-2025 | Gvoke Hypopen |
| Novo Nordisk INC | $198.57 | 2023-2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $136.75 | 2022-2023 | Korlym |
| Tandem Diabetes Care, INC. | $136.31 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $132.03 | 2022-2025 | |
| Cequr Corporation | $124.97 | 2023-2025 | Cequr Simplicity |
| Sanofi-Aventis U.S. LLC | $117.78 | 2022-2023 | |
| Abbott Laboratories | $112.70 | 2022-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.79 | 2023-2024 | Jardiance |
| Ascendis Pharma Endocrinology INC | $64.15 | 2023-2025 | Yorvipath |
| Medtronic, INC. | $60.52 | 2023-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Kyowa Kirin, INC. | $58.04 | 2023-2025 | Crysvita |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $55.28 | 2023-2025 | General - Erectile Dysfunction |
| Amneal Pharmaceuticals LLC | $37.20 | 2023 | Unithroid |
| Ibsa Pharma INC. | $35.03 | 2024 | Licart, Tirosint |
| Opko Pharmaceuticals, LLC | $34.49 | 2022-2023 | Rayaldee |
| Amgen INC. | $28.41 | 2022 | |
| Dexcom, INC. | $26.45 | 2023 | Dexcom G6 Transmitter |
| Alfasigma USA, INC. | $23.42 | 2022 | |
| Antares Pharma, INC. | $22.66 | 2023 | Tlando, Xyosted, Nocdurna |
| Nevro Corp. | $21.36 | 2023 | Senza |
| Insulet Corporation | $21.01 | 2023 | Omnipod |
| Amarin Pharma, INC. | $19.67 | 2022 | |
| Bigfoot Biomedical INC | $19.01 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.11 | 2023 | Adthyza |
| Mannkind Corporation | $16.79 | 2022 | |
| Merck Sharp & Dohme LLC | $14.31 | 2022 | |
| Sequel Med Tech, LLC | $13.61 | 2025 | Twiist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.